Speech and neuroimaging effects following HiCommunication: a randomized controlled group intervention trial in Parkinson’s disease
Brain Communications · 02.07.2024 · 6 (4)
DOI: 10.1093/braincomms/fcae235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Communications, online erschienen am 12.07.2024. Verfasst von Hanna Steurer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science, Intervention and Technology, Division of Speech and Language Pathology, Karolinska Institutet, 141 86 Huddinge, Stock…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Swedish Parkinson Foundation, Regional Agreement on Medical Training and Clinical Research.
Abstract (Originalsprache)
Speech, voice and communication changes are common in Parkinson's disease. HiCommunication is a novel group intervention for speech and communication in Parkinson’s disease based on principles driving neuroplasticity. In a randomized controlled trial, 95 participants with Parkinson’s disease were allocated to HiCommunication or an active control intervention. Acoustic analysis was performed pre-, post- and six months after intervention. Intention-to-treat analyses with missing values imputed in linear multilevel models and complimentary per-protocol analyses were performed. The proportion of participants with a clinically relevant increase in the primary outcome measure of voice sound level was calculated. Resting-state functional MRI was performed pre- and post-intervention. Spectral dynamic causal modelling and the parametric empirical Bayes methods were applied to resting-state functional MRI data to describe effective connectivity changes in a speech-motor-related network of brain regions. From pre- to post-intervention, there were significant group-by-time interaction effects for the measures voice sound level in text reading (unstandardized b = 2.3, P = 0.003), voice sound level in monologue (unstandardized b = 2.1, P = 0.009), Acoustic Voice Quality Index (unstandardized b = −0.5, P = 0.016) and Harmonics-to-Noise Ratio (unstandardized b = 1.3, P = 0.014) post-intervention. For 59% of the participants, the increase in voice sound level after HiCommunication was clinically relevant. There were no sustained effects at the six-month follow-up. In the effective connectivity analysis, there was a significant decrease in inhibitory self-connectivity in the left supplementary motor area and increased connectivity from the right supplementary motor area to the left paracentral gyrus after HiCommunication compared to after the active control intervention. In conclusion, the HiCommunication intervention showed promising effects on voice sound level and voice quality in people with Parkinson’s disease, motivating investigations of barriers and facilitators for implementation of the intervention in healthcare settings. Resting-state brain effective connectivity was altered following the intervention in areas implicated, possibly due to reorganization in brain networks.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Science, Intervention and Technology, Division of Speech and Language Pathology, Karolinska Institutet, 141 86 Huddinge, Stockholm, Sweden.
- Research & Development Unit, Stockholms Sjukhem, 112 19 Stockholm, Sweden.
- Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 141 83 Huddinge, Stockholm, Sweden.
- Women's Health and Allied Health Professionals Theme, Medical Unit Occupational Therapy & Physiotherapy, Karolinska University Hospital, 141 57 Huddinge, Stockholm, Sweden.
- School of Psychological Sciences, Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC, 3800, Australia.
- Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London WC1N 3AR, UK.
ORCID-Profile: Hanna Steurer, Franziska Albrecht, Joakim Körner Gustafsson, Adeel Razi, Erika Franzén, Ellika Schalling
Förderung
- Swedish Research Council
- Swedish Parkinson Foundation
- Regional Agreement on Medical Training and Clinical Research
- Stiftelsen Promobilia
- Neurofonden
- Stiftelsen Norrbacka-Eugenia
- Augusta and Petrus Hedlunds Stiftelse
- Stohnes Stiftelse and Aina Börjesons Stiftelse
Zitieren
APA
Steurer, H., Albrecht, F., Gustafsson, J. K., Razi, A., Franzén, E., & Schalling, E. (2024). Speech and neuroimaging effects following HiCommunication: a randomized controlled group intervention trial in Parkinson’s disease. Brain Communications, 6(4). https://doi.org/10.1093/braincomms/fcae235
Vancouver
Steurer H, Albrecht F, Gustafsson JK, Razi A, Franzén E, Schalling E. Speech and neuroimaging effects following HiCommunication: a randomized controlled group intervention trial in Parkinson’s disease. Brain Communications. 2024;6(4). doi:10.1093/braincomms/fcae235
BibTeX
@article{Steurer2024,
author = {Steurer, Hanna and Albrecht, Franziska and Gustafsson, Joakim Körner and Razi, Adeel and Franzén, Erika and Schalling, Ellika},
title = {Speech and neuroimaging effects following HiCommunication: a randomized controlled group intervention trial in Parkinson’s disease},
journal = {Brain Communications},
year = {2024},
volume = {6},
number = {4},
doi = {10.1093/braincomms/fcae235}
}
EUVIMED